Utama › Gangguan Depresi Major › Florida › Tampa
Kajian klinikal Gangguan Depresi Major di Tampa, FL
17 kajian untuk Gangguan Depresi Major sedang mencari peserta di lokasi dalam dan sekitar Tampa (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Mengambil pesertaFasa 3
- IPTB Clinical Research, Tampa
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Mengambil pesertaFasa 3
- Psych Me Medical Research Inc, Tampa
- Interventional Psychiatry of Tampa Bay, Tampa
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 2
- K2 Medical Research - Tampa, Tampa
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Mengambil pesertaFasa 3
- Interventional Psychiatry of Tampa Bay, Tampa
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Mengambil pesertaFasa 3
- K2 Medical Research Tampa, Tampa
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Mengambil pesertaFasa 4
- Neurocrine Clinical Site, Tampa
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Mengambil pesertaFasa 2
- IPTB Clinical Research, Tampa
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Mengambil pesertaFasa 2
- Draig Clinical Site, Tampa
- Draig Clinical Site, Tampa
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Mengambil peserta
- USF Health, Tampa
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Tampa
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Mengambil pesertaFasa 3
- K2 Medical Research (Tampa), Tampa
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Mengambil pesertaFasa 3
- K2 Medical Research - Tampa, Tampa
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Tampa
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Tampa
- Neurocrine Clinical Site, Tampa
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Mengambil pesertaFasa 2
- University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Mengambil pesertaFasa 2
- Autobahn Site #148, Tampa
Study of ALTO-300 in MDD
Mengambil pesertaFasa 2
- Site 221, Tampa
Kajian Gangguan Depresi Major di bandar lain
- New York City, NY37 kajian
- Boston, MA31 kajian
- Atlanta, GA25 kajian
- Philadelphia, PA23 kajian
- Orlando, FL19 kajian
- Miami, FL18 kajian
- Chicago, IL17 kajian
- Houston, TX16 kajian
- San Diego, CA16 kajian
- Little Rock, AR14 kajian
- Orange, CA13 kajian
- Austin, TX13 kajian
Kajian lain di Tampa
- Kanser Paru-paru Bukan Sel Kecil51 kajian
- Kanser Payudara43 kajian
- Kanser (semua jenis)39 kajian
- Kanser Kolorektal33 kajian
- Kanser Metastatik29 kajian
- Kanser Paru-paru29 kajian
- Leukemia Mieloid Akut29 kajian
- Kanser Pankreas26 kajian
- Kanser Ovari21 kajian
- Sindrom Mielodisplastik19 kajian
- Melanoma19 kajian
- Kegagalan Jantung18 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.